Smart Health Diagnostics (SHDx) specializes in precision diagnostics aimed at addressing unmet clinical needs in various high-risk diseases, including vascular and metabolic conditions. The company has developed a suite of diagnostic products, such as SMART Vascular Dx and SMART Diabetes Dx, which leverage advanced multi-modality technologies for disease detection. SHDx's approach integrates data from diverse sources, including proteomics, genetics, and imaging, to tackle complex clinical challenges. Their commitment to innovation is further underscored by ongoing projects in oncology, inflammatory diseases, and other critical health areas, as well as plans for facility expansion and strategic collaborations with major healthcare institutions.

In addition to its diagnostic products, SHDx emphasizes the importance of data-driven insights in healthcare. The SmartScience Dx platform features a substantial repository of approximately 195,000 curated serum samples, which supports extensive clinical studies and biomarker discovery. This resource enables rapid validation of current studies and facilitates cost-effective research without the need for patient enrollment. By combining cutting-edge science with proprietary analytics, Smart Health Diagnostics aims to enhance the quality of life for patients through timely and accurate disease detection, ultimately contributing to improved healthcare outcomes.

United States

SmartHealth Dx develops precision diagnostics that address unmet clinical needs in pathology and vascular inflammation for advancing today's standard.

Smart Health Diagnostics

Company Details